Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survival

Oncology Reports

Volumn 14, Issue 3, 2005, Pages 763-769

  El Hage, Faten ^a   Vergnon, Isabelle ^a   Grunenwald, Dominique ^b   Soria, Jean Charles ^a   Chouaib, Salem ^a   Mami Chouaib, Fathia ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Cytotoxic T lymphocyte; Non small cell lung cancer; Peripheral blood lymphocytes; T cell receptor; Tumor associated antigen; Tumor infiltrating lymphocyte

Indexed keywords

ACTIN BINDING PROTEIN; ACTININ; CYTOKINE; HLA A2 ANTIGEN;

AGED; ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; CYTOTOXICITY TEST; FLOW CYTOMETRY; FOLLOW UP; GENETICS; HUMAN; IMMUNOLOGY; LARGE CELL CARCINOMA; LUNG TUMOR; MALE; METABOLISM; MUTATION; PATHOLOGY; SECRETION;

ACTININ; AGED; CARCINOMA, LARGE CELL; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HLA-A2 ANTIGEN; HUMANS; LUNG NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MUTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 24644434451     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.3.763     Document Type: Article

References (19)

1. Yoshino I, Goedegebuure PS, Peoples GE, et at HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res 54: 3387-3390, 1994.
2. Hogan KT, Eisinger DP, Cupp SB, et al: The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. Cancer Res 58: 5144-5150, 1998. (Pubitemid 28521175)
3. Karanikas V, Colau D, Baurain JF, et al: High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival. Cancer Res 61: 3718-3724, 2001. (Pubitemid 32694985)
4. Gomi S, Nakao M, Niiya F, et al: A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J Immunol 163: 4994-5004, 1999. (Pubitemid 29501267)
5. Yamada A, Kawano K, Koga M, Takamori S, Nakagawa M and Itoh K: Gene and peptide analyses of newly defined lung cancer antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes. Cancer Res 63: 2829-2835, 2003. (Pubitemid 36667154)
6. Kawano K, Gomi S, Tanaka K, et al: Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer. Cancer Res 60: 3550-3558, 2000. (Pubitemid 30482176)
7. Echchakir H, Mami-Chouaib F, Vergnon I, et al: A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res 61: 4078-4083, 2001. (Pubitemid 32720974)
8. Echchakir H, Vergnon I, Dorothee G, Grunenwald D, Chouaib S and Mami-Chouaib F: Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung. Int Immunol 12: 537-546, 2000. (Pubitemid 30199359)
9. Echchakir H, Dorothee G, Vergnon I, Menez J, Chouaib S and Mami-Chouaib F: Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution. Proc Natl Acad Sci USA 99: 9358-9363, 2002. (Pubitemid 34764618)
10. Dorothee G, Echchakir H, Le Maux Chansac B, et al: Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. Oncogene 22: 7192-7198, 2003. (Pubitemid 37378551)
11. Altman JD, Moss PA, Goulder PJ, et al: Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96, 1996. (Pubitemid 26332731)
12. Dunbar PR, Ogg GS, Chen J, Rust N, van der Bruggen P and Cerundolo V: Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr Biol 8: 413-416, 1998. (Pubitemid 28174001)
13. Lee PP, Yee C, Savage PA, et al: Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5: 677-685, 1999. (Pubitemid 29289432)
14. Romero P, Dunbar PR, Valmori D, et al: Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 188: 1641-1650, 1998. (Pubitemid 28516109)
15. Valmori D, Dutoit V, Lienard D, et al: Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol 165: 533-538, 2000. (Pubitemid 30429548)
16. Honda K, Yamada T, Endo R, et at. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140: 1383-1393, 1998.
17. Nikolopoulos SN, Spengler BA, Kisselbach K, Evans AE, Biedler JL and Ross RA: The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 19: 380-386, 2000. (Pubitemid 30077338)
18. Menez J, Le Maux Chansac B, Dorothee G, et al: Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. Oncogene 23: 2630-2639, 2004.
19. Honda K, Yamada T, Seike M, et al: Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene 23: 5257-5262, 2004. (Pubitemid 38980358) Médicale